PSIP1 and lobular neoplasia: The high frequency of PLN patients in anti-dsDNA antibody-negative and anti-DFS70 antibody-positive LN patients also suggested that anti-DFS70 antibodies could serve as an alternative PLN predictive biomarker in anti-dsDNA antibody-negative LN patients.